(Q37689880)

English

The Soluble Epoxide Hydrolase Inhibitor AR9281 Decreases Blood Pressure, Ameliorates Renal Injury and Improves Vascular Function in Hypertension

scientific article published on 18 December 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

The Soluble Epoxide Hydrolase Inhibitor AR9281 Decreases Blood Pressure, Ameliorates Renal Injury and Improves Vascular Function in Hypertension (English)

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Soluble epoxide hydrolase

0 references

author name string

John D Imig

1

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Margaret A Carpenter

2

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Sean Shaw

3

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

publication date

18 December 2009

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Pharmaceuticals

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

217-227

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

copyright license

Creative Commons Attribution 4.0 International

18 December 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Soluble epoxide hydrolase, a target with multiple opportunities for cardiovascular drug discovery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Regulation of T-cell function by endogenously produced angiotensin II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Arachidonic acid cytochrome P450 epoxygenase pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Soluble epoxide hydrolase is a therapeutic target for acute inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Epoxide hydrolases: their roles and interactions with lipid metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Nitric oxide, angiotensin II, and reactive oxygen species in hypertension and atherogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Traditional and emerging cardiovascular risk factors in end-stage renal disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Immunosuppressive treatment protects against angiotensin II-induced renal damage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Renin-angiotensin system and renal damage: emerging data on angiotensin II as a proinflammatory mediator.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 August 2017

Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

14 September 2017

Attenuation of cisplatin nephrotoxicity by inhibition of soluble epoxide hydrolase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

23 June 2018

Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension

1 reference

https://api.crossref.org/works/10.3390%2FPH2030217

21 January 2018

Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats.

1 reference

https://api.crossref.org/works/10.3390%2FPH2030217

21 January 2018

Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids

1 reference

https://api.crossref.org/works/10.3390%2FPH2030217

21 January 2018

Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice

1 reference

https://api.crossref.org/works/10.3390%2FPH2030217

21 January 2018

Role of pressure in angiotensin II-induced renal injury: chronic servo-control of renal perfusion pressure in rats.

1 reference

https://api.crossref.org/works/10.3390%2FPH2030217

21 January 2018

Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.3390%2FPH2030217

21 January 2018

Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978544

1 September 2018

Renin-angiotensin system blockade improves endothelial dysfunction in hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/27713235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II, interstitial inflammation, and the pathogenesis of salt-sensitive hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/27713235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel nitric oxide synthase--dependent mechanism of vasorelaxation in small arteries from hypertensive rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/27713235

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3390/PH2030217

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37689880&oldid=2241184177"